Surgical and molecular pathology of barrett esophagus

Abstract

Background: Patients with Barrett esophagus (BE) are predisposed to developing dysplasia and cancer. Adenocarcinoma, which is associated with BE, is the most common type of esophageal tumor and, typically, it has an aggressive clinical course and a high rate of mortality, Methods: The English-language literature relating to tumor epidemiology, etiology, and the pathogenesis of BE was reviewed and summarized, Results: The role of pathologists in the diagnosis and pitfalls associated with grading Barrett dysplasia is addressed, Current molecular testing for Barrett neoplasia, as well as testing methods currently in development, is discussed, focusing on relevant tests for diagnosing tumor types, determining prognosis, and assessing therapeutic response, Conclusions: Grading is essential for developing appropriate treatment plans, follow-up visits, and therapeutic interventions for each patient, Familiarity with current molecular testing methods will help physicians correctly diagnose the disease and select the most appropriate therapy for each of their patients.